Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose escalation study of XEN-D0501 in adults with type 2 diabetes mellitus on metformin
2016-003843-12Phase 2Completed
- Sponsor
- Pila Pharma
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of XEN-D0501 in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Pila Pharma. Primary endpoint: Safety and tolerability of XEN-D0501. Started Jan 2017; status: completed.
02
Drugs
XEN-D0501
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2016-003843-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003843-12.